NUCLEOSIDE TRANSPORTERS: CNTs AND ENTs - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 195

human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2. J Biol Chem
274(35):24475-24484.
64. Lai Y, Lee EW, Ton CC, Vijay S, Zhang H, Unadkat JD. 2005. Conserved residues F316
and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitiv-
ity and membrane expression, respectively. Am J Physiol Cell Physiol 288(1):C39-C45.
65. Zhang J, Tackaberry T, Ritzel MW, Raborn T, Barron G, Baldwin SA, Young JD, Cass
CE. 2006. Cysteine-accessibility analysis of transmembrane domains 11-13 of human
concentrative nucleoside transporter 3. Biochem J 394(Pt 2):389-398.
66. Loewen SK, Yao SY, Slugoski MD, Mohabir NN, Turner RJ, Mackey JR, Weiner JH,
Gallagher MP, Henderson PJ, Baldwin SA, Cass CE, Young JD. 2004. Transport of phys-
iological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombi-
nant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis
oocytes. Mol Membr Biol 21(1):1-10.
67. Griffiths M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong FY, Coe
I, Cass CE, Young JD, Baldwin SA. 1997. Cloning of a human nucleoside transporter
implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med
3(1):89-93.
68. Yao SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, Young JD. 1997.
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-
sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins
(rENT1 and rENT2) from rat tissues. J Biol Chem 272(45):28423-28430.
69. Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR. 2000. Molecular
cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-
resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J
352(Pt 2):363-372.
70. Handa M, Choi DS, Caldeiro RM, Messing RO, Gordon AS, Diamond I. 2001. Cloning
of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter
(ENT1) lacking a putative phosphorylation site. Gene 262(1-2):301-307.
71. Jennings LL, Hao C, Cabrita MA, Vickers MF, Baldwin SA, Young JD, Cass CE. 2001.
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and
2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 40(5):722-
731.
72. Mangravite LM, Xiao G, Giacomini KM. 2003. Localization of human equilibrative
nucleoside transporters, hENT1 and hENT2, in renal epithelial cells. Am J Physiol Renal
Physiol 14:14.
73. Lai Y, Tse CM, Unadkat JD. 2004. Mitochondrial expression of the human equilibrative
nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral
drugs. J Biol Chem 279(6):4490-4497.
74. Lee EW, Lai Y, Zhang H, Unadkat JD. 2006. Identification of the mitochondrial targeting
signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for inter-
species differences in mitochondrial toxicity of fialuridine. J Biol Chem 281(24):16700-
16706.
75. Ward JL, Sherali A, Mo ZP, Tse CM. 2000. Kinetic and pharmacological properties of
cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed
in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine
and cytidine but a high affinity for inosine. J Biol Chem 275(12):8375-8381.